APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Psychiatry

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Personalized Psychiatry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026197 pages

Choose your research edition.

Industry ResearchPersonalized Psychiatry Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Psychiatry Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Personalized Psychiatry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Psychiatry Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Psychiatry Market Analysis and Forecast 2026-2032235 pages · $4,950 USD

Market perspective

The global Personalized Psychiatry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Personalized Psychiatry include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica and Akili Interactive, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Personalized Psychiatry market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Personalized Psychiatry and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Personalized Psychiatry revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Personalized Psychiatry market size, projected growth trends, production technologies, key applications, and end-use industries.

Personalized Psychiatry Segment by Company

COMPASS Pathways

Mindstrong Health

Pear Therapeutics

Cogito

Kaia Health

Sooma

GenoMind

Empatica

Akili Interactive

Neuroverse

Personalized Psychiatry Segment by Type

Depression and Anxiety

Bipolar Disorder

Addiction

Other

Personalized Psychiatry Segment by Application

Mental Health Professionals

Patients

Healthcare Providers

Personalized Psychiatry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Psychiatry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Psychiatry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Psychiatry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Personalized Psychiatry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Psychiatry industry.

Chapter 3: Detailed analysis of Personalized Psychiatry companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Psychiatryrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Personalized Psychiatry Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Depression and Anxiety Table 3. Key Players of Bipolar Disorder Table 4. Key Players of Addiction Table 3. Key Players of Other Table 4. Global Personalized Psychiatry Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Mental Health Professionals Table 6. Key Players of Patients Table 7. Key Players of Healthcare Providers Table 8. Global Personalized Psychiatry Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Personalized Psychiatry Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Personalized Psychiatry Market Share by Region (2021-2026) Table 11. Global Personalized Psychiatry Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Personalized Psychiatry Market Share by Region (2027-2032) Table 13. Personalized Psychiatry Industry Trends Table 14. Personalized Psychiatry Industry Drivers Table 15. Personalized Psychiatry Industry Opportunities and Challenges Table 16. Personalized Psychiatry Industry Restraints Table 17. Global Personalized Psychiatry Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Personalized Psychiatry Revenue Market Share by Company (2021-2026) Table 19. Global Personalized Psychiatry Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Personalized Psychiatry Key Company Head Office and Area Served Table 21. Global Personalized Psychiatry Company, Product Type & Application Table 22. Global Personalized Psychiatry Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Personalized Psychiatry by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Personalized Psychiatry Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Personalized Psychiatry Revenue Market Share by Type (2021-2026) Table 29. Global Personalized Psychiatry Revenue Market Share by Type (2027-2032) Table 30. Global Personalized Psychiatry Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Personalized Psychiatry Revenue Market Share by Application (2021-2026) Table 34. Global Personalized Psychiatry Revenue Market Share by Application (2027-2032) Table 35. COMPASS Pathways Company Information Table 36. COMPASS Pathways Business Overview Table 37. COMPASS Pathways Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. COMPASS Pathways Personalized Psychiatry Product Portfolio Table 39. COMPASS Pathways Recent Development Table 40. Mindstrong Health Company Information Table 41. Mindstrong Health Business Overview Table 42. Mindstrong Health Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Mindstrong Health Personalized Psychiatry Product Portfolio Table 44. Mindstrong Health Recent Development Table 45. Pear Therapeutics Company Information Table 46. Pear Therapeutics Business Overview Table 47. Pear Therapeutics Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pear Therapeutics Personalized Psychiatry Product Portfolio Table 49. Pear Therapeutics Recent Development Table 50. Cogito Company Information Table 51. Cogito Business Overview Table 52. Cogito Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Cogito Personalized Psychiatry Product Portfolio Table 54. Cogito Recent Development Table 55. Kaia Health Company Information Table 56. Kaia Health Business Overview Table 57. Kaia Health Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Kaia Health Personalized Psychiatry Product Portfolio Table 59. Kaia Health Recent Development Table 60. Sooma Company Information Table 61. Sooma Business Overview Table 62. Sooma Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sooma Personalized Psychiatry Product Portfolio Table 64. Sooma Recent Development Table 65. GenoMind Company Information Table 66. GenoMind Business Overview Table 67. GenoMind Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GenoMind Personalized Psychiatry Product Portfolio Table 69. GenoMind Recent Development Table 70. Empatica Company Information Table 71. Empatica Business Overview Table 72. Empatica Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Empatica Personalized Psychiatry Product Portfolio Table 74. Empatica Recent Development Table 75. Akili Interactive Company Information Table 76. Akili Interactive Business Overview Table 77. Akili Interactive Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Akili Interactive Personalized Psychiatry Product Portfolio Table 79. Akili Interactive Recent Development Table 80. Neuroverse Company Information Table 81. Neuroverse Business Overview Table 82. Neuroverse Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Neuroverse Personalized Psychiatry Product Portfolio Table 84. Neuroverse Recent Development Table 85. North America Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Personalized Psychiatry Market Size by Country (2021-2026) Table 91. North America Personalized Psychiatry Market Size by Country (2027-2032) Table 92. Europe Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Personalized Psychiatry Market Size by Country (2021-2026) Table 98. Europe Personalized Psychiatry Market Size by Country (2027-2032) Table 99. China Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 100. China Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 101. China Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 102. China Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Personalized Psychiatry Market Size by Country (2021-2026) Table 109. Asia Personalized Psychiatry Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Personalized Psychiatry Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Personalized Psychiatry Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Personalized Psychiatry Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Personalized Psychiatry Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Personalized Psychiatry Product Image Figure 2. Global Personalized Psychiatry Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Personalized Psychiatry Market Share by Type: 2025 VS 2032 Figure 4. Depression and Anxiety Image Figure 5. Bipolar Disorder Image Figure 6. Addiction Image Figure 7. Other Image Figure 8. Global Personalized Psychiatry Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Personalized Psychiatry Market Share by Application: 2025 VS 2032 Figure 10. Mental Health Professionals Image Figure 11. Patients Image Figure 12. Healthcare Providers Image Figure 13. Global Personalized Psychiatry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 15. Global Personalized Psychiatry Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Personalized Psychiatry Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Personalized Psychiatry Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Personalized Psychiatry Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Personalized Psychiatry Revenue Market Share by Type (2021-2032) Figure 22. Global Personalized Psychiatry Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Personalized Psychiatry Revenue Market Share by Application (2021-2032) Figure 24. North America Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 25. North America Personalized Psychiatry Market Share by Type (2021-2032) Figure 26. North America Personalized Psychiatry Market Share by Application (2021-2032) Figure 27. North America Personalized Psychiatry Market Share by Country (2021-2032) Figure 28. United States Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 29. Canada Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 31. Europe Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 32. Europe Personalized Psychiatry Market Share by Type (2021-2032) Figure 33. Europe Personalized Psychiatry Market Share by Application (2021-2032) Figure 34. Europe Personalized Psychiatry Market Share by Country (2021-2032) Figure 35. Germany Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 36. France Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 38. Italy Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 39. Russia Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 41. China Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 42. China Personalized Psychiatry Market Share by Type (2021-2032) Figure 43. China Personalized Psychiatry Market Share by Application (2021-2032) Figure 44. Asia Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 45. Asia Personalized Psychiatry Market Share by Type (2021-2032) Figure 46. Asia Personalized Psychiatry Market Share by Application (2021-2032) Figure 47. Asia Personalized Psychiatry Market Share by Country (2021-2032) Figure 48. Japan Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 52. India Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 53. Australia Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Personalized Psychiatry Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Personalized Psychiatry Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Personalized Psychiatry Market Share by Country (2021-2032) Figure 58. Brazil Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 63. UAE Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 65. Chile Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Depression and Anxiety
  • Bipolar Disorder
  • Addiction
  • Other
Applications
  • Mental Health Professionals
  • Patients
  • Healthcare Providers
Companies covered
  • COMPASS Pathways
  • Mindstrong Health
  • Pear Therapeutics
  • Cogito
  • Kaia Health
  • Sooma
  • GenoMind
  • Empatica
  • Akili Interactive
  • Neuroverse

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Personalized Psychiatry Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Depression and Anxiety
  5. 1.2.3 Bipolar Disorder
  6. 1.2.4 Addiction
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Personalized Psychiatry Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Mental Health Professionals
  11. 1.3.3 Patients
  12. 1.3.4 Healthcare Providers
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Personalized Psychiatry Growth Trends by Region
  15. 1.5.1 Global Personalized Psychiatry Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Personalized Psychiatry Market Size by Region (2021-2026)
  17. 1.5.3 Personalized Psychiatry Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Personalized Psychiatry Market Dynamics
  1. 2.1 Personalized Psychiatry Industry Trends
  2. 2.2 Personalized Psychiatry Industry Drivers
  3. 2.3 Personalized Psychiatry Industry Opportunities and Challenges
  4. 2.4 Personalized Psychiatry Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Personalized Psychiatry Revenue by Company (2021-2026)
  2. 3.2 Global Personalized Psychiatry Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Personalized Psychiatry Key Company Head office and Area Served
  4. 3.4 Global Personalized Psychiatry Company, Product Type & Application
  5. 3.5 Global Personalized Psychiatry Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Personalized Psychiatry Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Personalized Psychiatry Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Personalized Psychiatry Tier 1, Tier 2, and Tier 3
4 Personalized Psychiatry Market by Type
  1. 4.1 Global Personalized Psychiatry Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Personalized Psychiatry Market Size by Type (2021-2032)
  3. 4.3 Global Personalized Psychiatry Market Size Share by Type (2021-2032)
5 Personalized Psychiatry Market by Application
  1. 5.1 Global Personalized Psychiatry Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Personalized Psychiatry Market Size by Application (2021-2032)
  3. 5.3 Global Personalized Psychiatry Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 COMPASS Pathways
  2. 6.1.1 COMPASS Pathways Company Information
  3. 6.1.2 COMPASS Pathways Business Overview
  4. 6.1.3 COMPASS Pathways Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 COMPASS Pathways Personalized Psychiatry Product Portfolio
  6. 6.1.5 COMPASS Pathways Recent Developments
  7. 6.2 Mindstrong Health
  8. 6.2.1 Mindstrong Health Company Information
  9. 6.2.2 Mindstrong Health Business Overview
  10. 6.2.3 Mindstrong Health Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mindstrong Health Personalized Psychiatry Product Portfolio
  12. 6.2.5 Mindstrong Health Recent Developments
  13. 6.3 Pear Therapeutics
  14. 6.3.1 Pear Therapeutics Company Information
  15. 6.3.2 Pear Therapeutics Business Overview
  16. 6.3.3 Pear Therapeutics Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pear Therapeutics Personalized Psychiatry Product Portfolio
  18. 6.3.5 Pear Therapeutics Recent Developments
  19. 6.4 Cogito
  20. 6.4.1 Cogito Company Information
  21. 6.4.2 Cogito Business Overview
  22. 6.4.3 Cogito Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Cogito Personalized Psychiatry Product Portfolio
  24. 6.4.5 Cogito Recent Developments
  25. 6.5 Kaia Health
  26. 6.5.1 Kaia Health Company Information
  27. 6.5.2 Kaia Health Business Overview
  28. 6.5.3 Kaia Health Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Kaia Health Personalized Psychiatry Product Portfolio
  30. 6.5.5 Kaia Health Recent Developments
  31. 6.6 Sooma
  32. 6.6.1 Sooma Company Information
  33. 6.6.2 Sooma Business Overview
  34. 6.6.3 Sooma Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sooma Personalized Psychiatry Product Portfolio
  36. 6.6.5 Sooma Recent Developments
  37. 6.7 GenoMind
  38. 6.7.1 GenoMind Company Information
  39. 6.7.2 GenoMind Business Overview
  40. 6.7.3 GenoMind Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GenoMind Personalized Psychiatry Product Portfolio
  42. 6.7.5 GenoMind Recent Developments
  43. 6.8 Empatica
  44. 6.8.1 Empatica Company Information
  45. 6.8.2 Empatica Business Overview
  46. 6.8.3 Empatica Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Empatica Personalized Psychiatry Product Portfolio
  48. 6.8.5 Empatica Recent Developments
  49. 6.9 Akili Interactive
  50. 6.9.1 Akili Interactive Company Information
  51. 6.9.2 Akili Interactive Business Overview
  52. 6.9.3 Akili Interactive Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Akili Interactive Personalized Psychiatry Product Portfolio
  54. 6.9.5 Akili Interactive Recent Developments
  55. 6.10 Neuroverse
  56. 6.10.1 Neuroverse Company Information
  57. 6.10.2 Neuroverse Business Overview
  58. 6.10.3 Neuroverse Personalized Psychiatry Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Neuroverse Personalized Psychiatry Product Portfolio
  60. 6.10.5 Neuroverse Recent Developments
7 North America
  1. 7.1 North America Personalized Psychiatry Market Size (2021-2032)
  2. 7.2 North America Personalized Psychiatry Market Size by Type
  3. 7.2.1 North America Personalized Psychiatry Market Size by Type (2021-2026)
  4. 7.2.2 North America Personalized Psychiatry Market Size by Type (2027-2032)
  5. 7.2.3 North America Personalized Psychiatry Market Share by Type (2021-2032)
  6. 7.3 North America Personalized Psychiatry Market Size by Application
  7. 7.3.1 North America Personalized Psychiatry Market Size by Application (2021-2026)
  8. 7.3.2 North America Personalized Psychiatry Market Size by Application (2027-2032)
  9. 7.3.3 North America Personalized Psychiatry Market Share by Application (2021-2032)
  10. 7.4 North America Personalized Psychiatry Market Size by Country
  11. 7.4.1 North America Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Personalized Psychiatry Market Size by Country (2021-2026)
  13. 7.4.3 North America Personalized Psychiatry Market Size by Country (2027-2032)
  14. 7.4.4 North America Personalized Psychiatry Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Personalized Psychiatry Market Size (2021-2032)
  2. 8.2 Europe Personalized Psychiatry Market Size by Type
  3. 8.2.1 Europe Personalized Psychiatry Market Size by Type (2021-2026)
  4. 8.2.2 Europe Personalized Psychiatry Market Size by Type (2027-2032)
  5. 8.2.3 Europe Personalized Psychiatry Market Share by Type (2021-2032)
  6. 8.3 Europe Personalized Psychiatry Market Size by Application
  7. 8.3.1 Europe Personalized Psychiatry Market Size by Application (2021-2026)
  8. 8.3.2 Europe Personalized Psychiatry Market Size by Application (2027-2032)
  9. 8.3.3 Europe Personalized Psychiatry Market Share by Application (2021-2032)
  10. 8.4 Europe Personalized Psychiatry Market Size by Country
  11. 8.4.1 Europe Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Personalized Psychiatry Market Size by Country (2021-2026)
  13. 8.4.3 Europe Personalized Psychiatry Market Size by Country (2027-2032)
  14. 8.4.4 Europe Personalized Psychiatry Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Personalized Psychiatry Market Size (2021-2032)
  2. 9.2 China Personalized Psychiatry Market Size by Type
  3. 9.2.1 China Personalized Psychiatry Market Size by Type (2021-2026)
  4. 9.2.2 China Personalized Psychiatry Market Size by Type (2027-2032)
  5. 9.2.3 China Personalized Psychiatry Market Share by Type (2021-2032)
  6. 9.3 China Personalized Psychiatry Market Size by Application
  7. 9.3.1 China Personalized Psychiatry Market Size by Application (2021-2026)
  8. 9.3.2 China Personalized Psychiatry Market Size by Application (2027-2032)
  9. 9.3.3 China Personalized Psychiatry Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Personalized Psychiatry Market Size (2021-2032)
  2. 10.2 Asia Personalized Psychiatry Market Size by Type
  3. 10.2.1 Asia Personalized Psychiatry Market Size by Type (2021-2026)
  4. 10.2.2 Asia Personalized Psychiatry Market Size by Type (2027-2032)
  5. 10.2.3 Asia Personalized Psychiatry Market Share by Type (2021-2032)
  6. 10.3 Asia Personalized Psychiatry Market Size by Application
  7. 10.3.1 Asia Personalized Psychiatry Market Size by Application (2021-2026)
  8. 10.3.2 Asia Personalized Psychiatry Market Size by Application (2027-2032)
  9. 10.3.3 Asia Personalized Psychiatry Market Share by Application (2021-2032)
  10. 10.4 Asia Personalized Psychiatry Market Size by Country
  11. 10.4.1 Asia Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Personalized Psychiatry Market Size by Country (2021-2026)
  13. 10.4.3 Asia Personalized Psychiatry Market Size by Country (2027-2032)
  14. 10.4.4 Asia Personalized Psychiatry Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Personalized Psychiatry Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Personalized Psychiatry Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Personalized Psychiatry Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Personalized Psychiatry Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Personalized Psychiatry Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Personalized Psychiatry Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Personalized Psychiatry Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Personalized Psychiatry Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Personalized Psychiatry Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Personalized Psychiatry Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Personalized Psychiatry Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Personalized Psychiatry Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst